Cognition Therapeutics, Inc. (CGTX) Stock Forecast
Data as of May 8, 2026Healthcare · Current price $1.19 (+2.16%)
Consensus Target
—
Upside
—
Analysts
4
Rating
Buy(2.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
CGTX vs Sector & Market
| Metric | CGTX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 4 | 8 | 18 |
| Target Upside | — | +1148.8% | +14.9% |
| P/E Ratio | -4.85 | 3.11 | 27.95 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $19M | $19M | $19M | 2 |
| 2027-12-31 | $42M | $42M | $42M | 2 |
| 2028-12-31 | $4M | $4M | $4M | 1 |
| 2029-12-31 | $45M | $45M | $45M | 1 |
| 2030-12-31 | $113M | $113M | $113M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.45 | $-0.32 | $-0.14 | 4 |
| 2027-12-31 | $-0.50 | $-0.30 | $-0.19 | 3 |
| 2028-12-31 | $-0.29 | $-0.29 | $-0.29 | 1 |
| 2029-12-31 | $-0.25 | $-0.25 | $-0.25 | 1 |
| 2030-12-31 | $-0.19 | $-0.19 | $-0.19 | 1 |
Frequently Asked Questions
What is the analyst consensus for CGTX?
The consensus among 4 analysts covering Cognition Therapeutics, Inc. (CGTX) is Buy with an average price target of N/A.
How many analysts cover CGTX?
4 analysts have issued ratings for Cognition Therapeutics, Inc. in the past 12 months.
Is CGTX a buy or sell right now?
Based on 4 analyst ratings, CGTX has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for CGTX?
Analysts estimate CGTX will report EPS of $-0.32 for the period ending 2026-12-31, with revenue estimated at $19M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.